HLA class I antigen abnormalities and immune escape by malignant cells - PubMed (original) (raw)

Review

HLA class I antigen abnormalities and immune escape by malignant cells

Barbara Seliger et al. Semin Cancer Biol. 2002 Feb.

No abstract available

PubMed Disclaimer

Similar articles

• The role of classical and non-classical HLA class I antigens in human tumors.
  Bukur J, Jasinski S, Seliger B. Bukur J, et al. Semin Cancer Biol. 2012 Aug;22(4):350-8. doi: 10.1016/j.semcancer.2012.03.003. Epub 2012 Mar 24. Semin Cancer Biol. 2012. PMID: 22465194 Review.
• HLA-G proteins in cancer: do they provide tumor cells with an escape mechanism?
  Rouas-Freiss N, Moreau P, Ferrone S, Carosella ED. Rouas-Freiss N, et al. Cancer Res. 2005 Nov 15;65(22):10139-44. doi: 10.1158/0008-5472.CAN-05-0097. Cancer Res. 2005. PMID: 16287995
• MHC class I antigens, immune surveillance, and tumor immune escape.
  Garcia-Lora A, Algarra I, Garrido F. Garcia-Lora A, et al. J Cell Physiol. 2003 Jun;195(3):346-55. doi: 10.1002/jcp.10290. J Cell Physiol. 2003. PMID: 12704644 Review.
• HLA class I antigen loss, tumor immune escape and immune selection.
  Campoli M, Chang CC, Ferrone S. Campoli M, et al. Vaccine. 2002 Dec 19;20 Suppl 4:A40-5. doi: 10.1016/s0264-410x(02)00386-9. Vaccine. 2002. PMID: 12477427 Review.
• The biological consequences of altered MHC class I expression in tumours.
  Algarra I, Gaforio JJ, Cabrera T, Collado A, Garrido F. Algarra I, et al. J Biol Regul Homeost Agents. 1999 Apr-Jun;13(2):90-6. J Biol Regul Homeost Agents. 1999. PMID: 10503731 Review.

Cited by

• The identification of a N6-methyladenosin-modifed immune pattern to predict immunotherapy response and survival in urothelial carcinoma.
  Mao X, Chen X, Xu Z, Ding L, Luo W, Lin Y, Wang R, Xia L, Wang M, Li G. Mao X, et al. Aging (Albany NY). 2024 May 1;16(9):7774-7798. doi: 10.18632/aging.205782. Epub 2024 May 1. Aging (Albany NY). 2024. PMID: 38696324 Free PMC article.
• Potential Molecular Markers Related to Lymph Node Metastasis and Stalk Resection Margins in Pedunculated T1 Colorectal Cancers Using Digital Spatial Profiling: A Pilot Study with a Small Case Series.
  Kwon MJ, Park HY, Lim H, Son IT, Kim MJ, Kim NY, Kim MJ, Nam ES, Cho SJ, Bang WJ, Kang HS. Kwon MJ, et al. Int J Mol Sci. 2024 Jan 16;25(2):1103. doi: 10.3390/ijms25021103. Int J Mol Sci. 2024. PMID: 38256174 Free PMC article.
• Protein disulfide isomerase A3 as novel biomarker for endometrial cancer.
  Yu F, Liu X, Li M, Liu X, Wang X, Guo M. Yu F, et al. Front Oncol. 2023 Oct 16;13:1247446. doi: 10.3389/fonc.2023.1247446. eCollection 2023. Front Oncol. 2023. PMID: 37909009 Free PMC article.
• High-plex spatial transcriptomic profiling reveals distinct immune components and the HLA class I/DNMT3A/CD8 modulatory axis in mismatch repair-deficient endometrial cancer.
  Guo J, Tang B, Fu J, Zhu X, Xie W, Wang N, Ding Z, Song Z, Yang Y, Xu G, Xiao X. Guo J, et al. Cell Oncol (Dordr). 2024 Apr;47(2):573-585. doi: 10.1007/s13402-023-00885-8. Epub 2023 Oct 17. Cell Oncol (Dordr). 2024. PMID: 37847338 Free PMC article.
• Transcriptomic insights into adenoid cystic carcinoma via RNA sequencing.
  Tang YF, An PG, Gu BX, Yi S, Hu X, Wu WJ, Zhang J. Tang YF, et al. Front Genet. 2023 Apr 21;14:1144945. doi: 10.3389/fgene.2023.1144945. eCollection 2023. Front Genet. 2023. PMID: 37152992 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations

• Research Materials

  • NCI CPTC Antibody Characterization Program